Weekly shot tested to fight debilitating eye weakness
NCT ID NCT07249632
Summary
This study is testing if a weekly injection called telitacicept can better control the symptoms of ocular myasthenia gravis, a condition that causes muscle weakness around the eyes. About 120 participants, aged 12 to 80, will receive either the drug or a placebo for 24 weeks while staying on their standard care. The main goal is to see if the drug improves patient-reported eye weakness scores more than the placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS, OCULAR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Hospital
RECRUITINGBeijing, Beijing Municipality, 100000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.